8th Nov 2016 17:04
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 7,398,066 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 3,867,264 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 3,530,802 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline Share Option Plan - ADS | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 9,883,088 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 533,350 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 9,349,738 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | Glaxo Wellcome UK Share Option Scheme | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 5,119,750 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,119,750 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | Glaxo Wellcome International Share Option Scheme | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 13,267,156 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 13,267,156 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | Glaxo Wellcome 1999 Share Option Plan | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 1,040,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,040,000 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 163,606 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 163,606 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 275,420 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 275,420 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 100,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 100,000 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline Savings Related Share Option Scheme | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 2,742,626 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,742,626 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 8 November 2016
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline plc Sharesave Plan 2012 | |||
Period of return: | From: | 1 May 2016 | To: | 31 October 2016 |
Balance of unallotted securities under scheme(s) from previous return: | 494,191 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 255,084 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 239,107 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
Related Shares:
Glaxosmithkline